JCR Pharmaceuticals and Modalis Therapeutics enter next phase in gene therapy research

JCR Pharmaceuticals Co., Ltd. (TSE:4552) and Modalis Therapeutics Corporation (TSE:4883) have announced a pivotal advancement in their joint efforts to develop an innovative gene therapy ... Read More